Hyperphosphatemia and karbamylation proteins — risk factors for cardiovascular disease
Journal Title: Східноєвропейський журнал внутрішньої та сімейної медицини - Year 2017, Vol 2017, Issue 1
Abstract
The paper presents the data of their research and presented the latest information on new, non-traditional risk factors for cardiovascular events in patients with chronic kidney disease. It is shown that the content of FGF23 (one of the new risk factors for cardiovascular complications) in patients with diabetic nephropathy directly adjusts the level of hyperphosphatemia and renal functional reserve decrease — with development karbamylation proteins.
Authors and Affiliations
I. I. Topchii
Keywords
Related Articles
- EP ID EP235485
- DOI 10.15407/internalmed2017.01.039
- Views 111
- Downloads 0
Clinical diagnostic algorithms of opioid dependence
In an article for the purposes of postgraduate training didactics narcologists described algorithmic foundationsof one of the most common forms of drug addiction — opioid addiction. The urgency of the problem, its histor...
Hyperphosphatemia and karbamylation proteins — risk factors for cardiovascular disease
The paper presents the data of their research and presented the latest information on new, non-traditional risk factors for cardiovascular events in patients with chronic kidney disease. It is shown that the content of F...
Palliative medicine and family doctor – past, present, future
Modern concepts about palliative medicine (PM), palliative and hospice care (PHC) are represented in the article. Authors have covered history of PM and PHC, philosophical foundations, principles, objectives and purposes...
Acute kidney injury: modern view of problem
The modern view of acute kidney injury as a global issue is presented in this article. The application of the concept of acute kidney injury in practical public health care is viewed as a strategic approach to reducing o...
Phatological state after cholecystectomy: from pathogenesis to treatment
Considered a pathological condition after cholecystectomy (biliary dysfunction, lesions esophagogastroduodenal zone halogena diarrhea, changes in the microbiome of the intestine). Their availability determines the therap...